It is reported that ductal pancreatic adenocarcinoma and intrahepatic cholangiocarcinoma are associated with decreased TRIC expression, correlating with a poor prognosis [16]. This evidence concerns the gene MARVELD2 and pancreatic ductal adenocarcinoma.